Azacitidine in Treating Patients With Previously Treated Advanced Non-Small Cell Lung Cancer

Summary

This phase II clinical trial is studying how well azacitidine works in treating patients with previously treated advanced non-small cell lung cancer. Drugs used in chemotherapy, such as azacitidine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.

Timeline

Start

2011-01-12

Primary completion

2011-04-15

Completion

2012-09-12

Drugs

Indications